Large.jpg

PATENTS


LITIGATION EXPERIENCE


SELECTED APPEARANCES FROM
40 TRIALS

  • Bombardier Recreational Products Inc v Arctic Cat Inc (2017) FC 207 and 2020 FC 691 (snowmobile)

  • Pollard Banknote v Scientific Games (2016) FC 883 (instant lottery tickets)

  • SNF v Ciba and BASF (2015) FC 997 (process of treating tailings)

  • The Dow Chemical Company v Nova Chemicals (2014) FC 326 (polyethylene)

  • J&J v Boston Scientific (2008) 71 C.P.R (4th) 123
    (coronary stent)

  • Whirlpool Corp v General Electric Co (1998), 76 C.P.R. (3d) 150 (washing machine)

  • AT&T Technologies Inc v Mitel Corp (1989), 26 C.P.R. (3d) 238 (transistor)

  • Windsurfing v Trilantic (1985), 3 C.P.R. (3d) 95
    (windsurfer)

  • Teledyne Industries v Lido (1983), 68 C.P.R. (2d) 204 (showerhead)

  • Scott Paper Co v 3M (1981), 53 C.P.R. (2d) 26
    (lithography)

  • Procter & Gamble v Calgon (1981), 56 C.P.R. (2d) 214 (clothes softener sheet)

  • Xerox Canada v IBM Canada (1978), 33 C.P.R. (2d) 24 (photocopier)

APPEARANCES IN THE
SUPREME COURT OF CANADA

Whirlpool v Camco (General Electric) [2000] 2 S.C.R. 1067

One of the two seminal cases on patent claim construction in Canada.

EXPERT EVIDENCE

Commonwealth of Australia v Sanofi-Aventis (NSD1639/2007)

Delivered an expert report in August, 2017 to Counsel for Sanofi-Aventis in the Federal Court of Australia on entitlement to remedies for patent infringement in Canada relating to a claim for damages by Australia as a result of being delayed from listing a generic drug on its formulary due to interlocutory injunction that was ultimately set aside.

Apotex Corp v Kyorin Pharmaceutical Co, Ltd, and Allergan, Inc (U.S.D.C. for the District of Delaware – 12-cv-196 SLR)

Delivered an expert report in Q1 2017 to American law firm Gibson Dunn (Counsel for the defendant, Allergan) and gave deposition in Q2 2017 concerning the enforcement of Canadian patents and related aspects of the Canadian system for the market approval of pharmaceutical drug products, as related to the medicine ZYMAR (gatifloxacin).

Eli Lilly v Government of Canada (Arbitration pursuant to Chapter 11, NAFTA)

Delivered two expert reports and gave testimony at Arbitration in Washington DC in May and June 2016 on patent law and practice in Canada.

Apotex Pty Ltd v Sanofi-Aventis (NSD1639/2007 New South Wales – Federal Court of Australia)

Delivered an expert report to the Australian law firm, Allens Linklater, who were acting for Sanofi on the remedies available under Canadian patent law to a patentee whose Canadian patent is infringed, particularly in the context of the Canadian clopidogrel litigation between Sanofi and Apotex.

Eli Lilly Canada Inc, et al v Novopharm Limited
(Federal Court File No. T-1048-07)

Delivered an expert affidavit to counsel for Eli Lilly on procedural timing under the Federal Courts Rules as it related to the existing proceedings in the patent infringement action concerning olanzapine.

Teva Canada Limited v Novartis AG
(Federal Court File No. T-2021-10)

Delivered an expert ‎affidavit counsel for Novartis on the implications of various procedural options in a patent impeachment action related to imatinib mesylate.

Sanofi-Aventis, Sanofi-Synthelabo Inc, Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v Apotex Inc and Apotex Corp (U.S.D.C. of Southern New York – 02-CV-2255)

Delivered an expert report to American law firm Cravath, Swaine & Moore LLP (Sanofi's counsel) on the “preclusive effect” of a decision under the Patented Medicines (Notice of Compliance) Regulations on later proceedings.

Apotex v Sanofi-Aventis, Sanofi-Synthelabo Inc, Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (Ontario Superior Court File No. 07-CV-331399PD2)

Delivered an expert report to counsel for Bristol-Myers Squibb and Sanofi, explaining the Patented Medicines (Notice of Compliance) Regulations and its procedures and practice in Canada.

Cellularvision Technology & Telecommunications, LP, v WIC Amalco, Inc, Canwest Global Communications Corp and Shaw Communications Inc,
(U.S.D.C. Southern District of New Year - 01-CV-4094 (RC) (DFE)

Delivered an expert affidavit to counsel for the defendants on patent claim construction and infringement in Canada.

Schlumberger Technology Corporation and Schlumberger Canada Limited v Baker Hughes Incorporated (American Arbitration Association Case No. 50198T0011810)

Delivered an expert affidavit to Baker & McKenzie LLP on patent law and practice in Canada.


Patent Lectures and Editorial Appointments

  • Lecturer in LL.M. program for Osgoode Hall Law School of York University (Intellectual Property Remedies), tri-annually
    (1998-2016)

  • Lecturer in Guest Speaker Series in Patents at Osgoode Hall Law School on “Patent Specifications, Claim Construction and Patent Infringement”, annually
    (2003-2021)

  • Lecturer in LL.B. program for Queen’s University Law School (Advanced Patents), autumn semester, 2000

 

ACCOLADES FOR PATENT LITIGATION

Ron Dimock is a go-to patent litigator and an all-around superstar”
- IP litigation - Who’s Who Legal (2020)

The “Dean of the Patent Bar”
- Who’s Who Patents (2013)

“Ron might actually be the most experienced patent trial lawyer in the country.”
- IAM Patent 1000 (2018)

Inducted into LMG Hall of Fame for Life Sciences Lawyers
- September 2018

“Chairman of the Board for Canadian Patent Lawyers.”
- IAM Patent 1000

“Ron Dimock at Gowling WLG is an all-round superstar in IP litigation with a strong record of representing clients before all levels of the Canadian Courts”
- Patents Who’s Who Legal 2021

“The firm (Gowlings) also brought on gold-ranked Ronald Dimock from DLA Piper, who knows everything there is to know about patent law after four decades of litigating before the Federal and Supreme Courts”
– IAM Patents (2020)

Ron Dimock (most highly regarded) receives high praise from market commentators this year, who describe him as “certainly at the top of the patent game” and as “a pre-eminent patent lawyer in the market.”
- Patents Who’s Who Legal - 2019

“Ron Dimock ranks among the elite practitioners in the North American market, having litigated in more than 400 patent disputes over the course of his career.”
- Who’s Who Legal - 2018

“Clients are effusive in their praise of Ronald Dimock: "In the realm of IP attorneys, he's a little bit of a rock star." They add: "He does not play down anything. You understand where he's coming from." He is deeply experienced before all levels of court in Canada and is regularly involved in high-profile litigious IP matters.”
- Star Ranking - Chambers Canada Guide - 2017

“Peers refer to Ron Dimock as one of the “shrewdest” patent litigators in the business, commend him as an “excellent” practitioner, and add “he is one of the most experienced IP litigators in Canada.”
- Managing Intellectual Property - IP Star - 2016

“The “just outstanding” Ronald Dimock is regularly seen on prominent patent litigation cases, offering clients over 40 years of experience.”
- Who’s Who Legal Canada - 2016

“Patent litigation "heavyweight" Ron Dimock "a tremendous litigator", with peers particularly admiring "his impressive client-handling skills". Ronald Dimock is a patents disputes specialist, with experience in mediation, litigation and arbitration. He is a “highflyer" and a "first rate disputes lawyer".
- Who’s Who - 2015